Paper9028353
Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma.
Hertervig E and 3 others. Cancer, 1997. Cited by 102 papers, by iCite.
Cite this record
ConductScience Library. Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Papers, record 9028353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9028353
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Sphingomyelin Phosphodiesterase | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Alkaline Phosphatase | |
| Amidohydrolases | |
| Ceramidases | |
| Female | |
| Humans | |
| Intestinal Mucosa | |
| Male | |
| Middle Aged |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42853313 | The sphingolipid code of cancer: divergent roles across tumor types and therapeutic horizons. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42853313 | PubMed |
| 39767749 | The Role of Sphingolipid Metabolism in Pregnancy-Associated Breast Cancer After Chemotherapy. | Biomedicines | 2024 | https://conductscience.org/library/papers/39767749 | PubMed |
| 37108361 | The Effect of Silencing the Genes Responsible for the Level of Sphingosine-1-phosphate on the Apoptosis of Colon Cancer Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108361 | PubMed |
| 36741374 | Alkaline sphingomyelinase (NPP7) impacts the homeostasis of intestinal T lymphocyte populations. | Front Immunol | 2022 | https://conductscience.org/library/papers/36741374 | PubMed |
| 36348490 | Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase. | Cancer Cell Int | 2022 | https://conductscience.org/library/papers/36348490 | PubMed |
| 34998898 | Ceramide signaling in the gut. | Mol Cell Endocrinol | 2022 | https://conductscience.org/library/papers/34998898 | PubMed |
| 34806320 | Progression of diabetes is associated with changes in the ileal transcriptome and ileal-colon morphology in the UC Davis Type 2 Diabetes Mellitus rat. | Physiol Rep | 2021 | https://conductscience.org/library/papers/34806320 | PubMed |
| 30963461 | Clinical application of ceramide in cancer treatment. | Breast Cancer | 2019 | https://conductscience.org/library/papers/30963461 | PubMed |
| 30371875 | Characterization of Sphingomyelin Phosphodiesterase Expression in Bumblebee (Bombus lantschouensis). | J Insect Sci | 2018 | https://conductscience.org/library/papers/30371875 | PubMed |
| 30087205 | Deficiency of alkaline SMase enhances dextran sulfate sodium-induced colitis in mice with upregulation of autotaxin. | J Lipid Res | 2018 | https://conductscience.org/library/papers/30087205 | PubMed |
| 29527260 | Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases: A field that needs to be closely studied. | World J Hepatol | 2018 | https://conductscience.org/library/papers/29527260 | PubMed |
| 28686076 | Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer. | Cancer Biol Ther | 2017 | https://conductscience.org/library/papers/28686076 | PubMed |
| 28314284 | Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study. | Anticancer Res | 2017 | https://conductscience.org/library/papers/28314284 | PubMed |
| 28292932 | Crystal structure of the human alkaline sphingomyelinase provides insights into substrate recognition. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28292932 | PubMed |
| 28083512 | Targeting Phospholipid Metabolism in Cancer. | Front Oncol | 2016 | https://conductscience.org/library/papers/28083512 | PubMed |
| 27692180 | Metabolic Regulation of Apoptosis in Cancer. | Int Rev Cell Mol Biol | 2016 | https://conductscience.org/library/papers/27692180 | PubMed |
| 27609772 | Role of neutral ceramidase in colon cancer. | FASEB J | 2016 | https://conductscience.org/library/papers/27609772 | PubMed |
| 25595595 | Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia. | Lipids | 2015 | https://conductscience.org/library/papers/25595595 | PubMed |
| 25100243 | Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography. | BMC Gastroenterol | 2014 | https://conductscience.org/library/papers/25100243 | PubMed |
| 24970218 | Re-configuration of sphingolipid metabolism by oncogenic transformation. | Biomolecules | 2014 | https://conductscience.org/library/papers/24970218 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ENPP7 | 339221 | PubTator's text mining | https://conductscience.org/library/genes/339221 | NCBI Gene |
| SMPD1 | 6609 | PubTator's text mining | https://conductscience.org/library/genes/6609 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9028353
GET https://conductscience.org/api/papers/v1/9028353/cited_by?page=2